236 related articles for article (PubMed ID: 31776384)
1. Pre-diagnosing and managing patients with GM1 gangliosidosis and related disorders by the evaluation of GM1 ganglioside content.
Tonin R; Caciotti A; Procopio E; Fischetto R; Deodato F; Mancardi MM; Di Rocco M; Ardissone A; Salviati A; Marangi A; Strisciuglio P; Mangone G; Casini A; Ricci S; Fiumara A; Parini R; Pavone FS; Guerrini R; Calamai M; Morrone A
Sci Rep; 2019 Nov; 9(1):17684. PubMed ID: 31776384
[TBL] [Abstract][Full Text] [Related]
2. Substrate reduction therapy with Miglustat in pediatric patients with GM1 type 2 gangliosidosis delays neurological involvement: A multicenter experience.
Fischetto R; Palladino V; Mancardi MM; Giacomini T; Palladino S; Gaeta A; Di Rocco M; Zampini L; Lassandro G; Favia V; Tripaldi ME; Strisciuglio P; Romano A; Severino M; Morrone A; Giordano P
Mol Genet Genomic Med; 2020 Oct; 8(10):e1371. PubMed ID: 32779865
[TBL] [Abstract][Full Text] [Related]
3. Novel Drug Candidates Improve Ganglioside Accumulation and Neural Dysfunction in GM1 Gangliosidosis Models with Autophagy Activation.
Kajihara R; Numakawa T; Odaka H; Yaginuma Y; Fusaki N; Okumiya T; Furuya H; Inui S; Era T
Stem Cell Reports; 2020 May; 14(5):909-923. PubMed ID: 32302553
[TBL] [Abstract][Full Text] [Related]
4. [The metabolism of radiolabelled GM1-ganglioside in cultured skin fibroblasts from controls and patients with GM1-gangliosidosis].
Inui K
Nihon Rinsho; 1995 Dec; 53(12):3102-4. PubMed ID: 8577066
[TBL] [Abstract][Full Text] [Related]
5. Uptake and metabolism of radiolabelled GM1-ganglioside in skin fibroblasts from controls and patients with GM1-gangliosidosis.
Midorikawa M; Inui K; Okada S; Yabuuchi H; Ogura K; Handa S
J Inherit Metab Dis; 1991; 14(5):721-9. PubMed ID: 1779618
[TBL] [Abstract][Full Text] [Related]
6. Fluorescent In Situ Staining and Flow Cytometric Procedures as New Pre-Diagnostic Tests for Sialidosis, GM1 Gangliosidosis and Niemann-Pick Type C.
Capitini C; Feo F; Caciotti A; Tonin R; Lulli M; Coviello D; Guerrini R; Calamai M; Morrone A
Biomedicines; 2022 Aug; 10(8):. PubMed ID: 36009508
[TBL] [Abstract][Full Text] [Related]
7. Cerebrospinal fluid biomarkers showing neurodegeneration in dogs with GM1 gangliosidosis: possible use for assessment of a therapeutic regimen.
Satoh H; Yamato O; Asano T; Yonemura M; Yamauchi T; Hasegawa D; Orima H; Arai T; Yamasaki M; Maede Y
Brain Res; 2007 Feb; 1133(1):200-8. PubMed ID: 17196562
[TBL] [Abstract][Full Text] [Related]
8. Effects of cyclodextrins on GM1-gangliosides in fibroblasts from GM1-gangliosidosis patients.
Maeda Y; Motoyama K; Higashi T; Horikoshi Y; Takeo T; Nakagata N; Kurauchi Y; Katsuki H; Ishitsuka Y; Kondo Y; Irie T; Furuya H; Era T; Arima H
J Pharm Pharmacol; 2015 Aug; 67(8):1133-42. PubMed ID: 25851126
[TBL] [Abstract][Full Text] [Related]
9. N-butyldeoxygalactonojirimycin reduces neonatal brain ganglioside content in a mouse model of GM1 gangliosidosis.
Kasperzyk JL; El-Abbadi MM; Hauser EC; D'Azzo A; Platt FM; Seyfried TN
J Neurochem; 2004 May; 89(3):645-53. PubMed ID: 15086521
[TBL] [Abstract][Full Text] [Related]
10. The treatment of juvenile/adult GM1-gangliosidosis with Miglustat may reverse disease progression.
Deodato F; Procopio E; Rampazzo A; Taurisano R; Donati MA; Dionisi-Vici C; Caciotti A; Morrone A; Scarpa M
Metab Brain Dis; 2017 Oct; 32(5):1529-1536. PubMed ID: 28577204
[TBL] [Abstract][Full Text] [Related]
11. Increased concentration of GM1-ganglioside in cerebrospinal fluid in dogs with GM1- and GM2-gangliosidoses and its clinical application for diagnosis.
Satoh H; Yamato O; Asano T; Yamasaki M; Maede Y
J Vet Diagn Invest; 2004 May; 16(3):223-6. PubMed ID: 15152837
[TBL] [Abstract][Full Text] [Related]
12. Incorporation and degradation of GM1 ganglioside and asialoGM1 ganglioside in cultured fibroblasts from normal individuals and patients with beta-galactosidase deficiency.
Kobayashi T; Shinnoh N; Kuroiwa Y
Biochim Biophys Acta; 1986 Jan; 875(1):115-21. PubMed ID: 3079639
[TBL] [Abstract][Full Text] [Related]
13. Rapid Identification of New Biomarkers for the Classification of GM1 Type 2 Gangliosidosis Using an Unbiased
Percival BC; Latour YL; Tifft CJ; Grootveld M
Cells; 2021 Mar; 10(3):. PubMed ID: 33807817
[TBL] [Abstract][Full Text] [Related]
14. G(M1)-ganglioside degradation and biosynthesis in human and murine G(M1)-gangliosidosis.
Sano R; Trindade VM; Tessitore A; d'Azzo A; Vieira MB; Giugliani R; Coelho JC
Clin Chim Acta; 2005 Apr; 354(1-2):131-9. PubMed ID: 15748609
[TBL] [Abstract][Full Text] [Related]
15. Substrate reduction reduces gangliosides in postnatal cerebrum-brainstem and cerebellum in GM1 gangliosidosis mice.
Kasperzyk JL; d'Azzo A; Platt FM; Alroy J; Seyfried TN
J Lipid Res; 2005 Apr; 46(4):744-51. PubMed ID: 15687347
[TBL] [Abstract][Full Text] [Related]
16. Sialidase NEU3 action on GM1 ganglioside is neuroprotective in GM1 gangliosidosis.
Allende ML; Lee YT; Byrnes C; Li C; Tuymetova G; Bakir JY; Nicoli ER; James VK; Brodbelt JS; Tifft CJ; Proia RL
J Lipid Res; 2023 Dec; 64(12):100463. PubMed ID: 37871851
[TBL] [Abstract][Full Text] [Related]
17. GM1-gangliosidosis in a cross-bred dog confirmed by detection of GM1-ganglioside using electrospray ionisation-tandem mass spectrometry.
Whitfield P; Johnson AW; Dunn KA; Delauche AJ; Winchester BG; Franklin RJ
Acta Neuropathol; 2000 Oct; 100(4):409-14. PubMed ID: 10985700
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of N-nonyl-deoxygalactonojirimycin as a pharmacological chaperone for human GM1 gangliosidosis leads to identification of a feline model suitable for testing enzyme enhancement therapy.
Rigat BA; Tropak MB; Buttner J; Crushell E; Benedict D; Callahan JW; Martin DR; Mahuran DJ
Mol Genet Metab; 2012 Sep; 107(1-2):203-12. PubMed ID: 22784478
[TBL] [Abstract][Full Text] [Related]
19. Infantile gangliosidoses: Mapping a timeline of clinical changes.
Jarnes Utz JR; Kim S; King K; Ziegler R; Schema L; Redtree ES; Whitley CB
Mol Genet Metab; 2017 Jun; 121(2):170-179. PubMed ID: 28476546
[TBL] [Abstract][Full Text] [Related]
20. GM1-gangliosidosis: accumulation of ganglioside GM1 in cultured skin fibroblasts and correlation with clinical types.
Suzuki Y; Nakamura N; Fukuoka K
Hum Genet; 1978 Aug; 43(2):127-31. PubMed ID: 99363
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
